Cargando…
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
BACKGROUND: The psychedelic 5-MeO-DMT has shown clinical potential due to its short duration and ability to induce mystical experiences. However, a phenomenon known as “reactivations” (similar to “flashbacks”) is a poorly understood and frequently reported phenomenon which appears associated with 5-...
Autores principales: | Ortiz Bernal, Ana María, Raison, Charles L., Lancelotta, Rafael L., Davis, Alan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745201/ https://www.ncbi.nlm.nih.gov/pubmed/36523876 http://dx.doi.org/10.3389/fpsyt.2022.1049643 |
Ejemplares similares
-
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
por: Reckweg, Johannes T., et al.
Publicado: (2022) -
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
por: Uthaug, Malin V, et al.
Publicado: (2019) -
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
por: Reckweg, Johannes T., et al.
Publicado: (2023) -
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
por: Szabo, Attila, et al.
Publicado: (2014) -
Pharmacokinetics of N,N-dimethyltryptamine in Humans
por: Good, Meghan, et al.
Publicado: (2023)